Ranbaxy declared on 19 Jan 2010 its decision to acquire Bangakore based Biovel Lifesciences. The acquiring of Biovel will give Ranbaxy access to Biovel’s intellectual property, know-how and manufacturing facility. Typhoid Vi antigen and Hib conjugate vaccines for which Ranbaxy has the regulatory approvals in India are the products that will be covered under this transaction. Ranbaxy is one of the world’s top 10 generic pharmaceutical companies.
Your career begins here! At Jagranjosh.com, our vision is to enable the youth to make informed life decisions, and our mission is to create credible and actionable content that answers questions or solves problems for India’s share of Next Billion Users. As India’s leading education and career guidance platform, we connect the dots for students, guiding them through every step of their journey—from excelling in school exams, board exams, and entrance tests to securing competitive jobs and building essential skills for their profession. With our deep expertise in exams and education, along with accurate information, expert insights, and interactive tools, we bridge the gap between education and opportunity, empowering students to confidently achieve their goals.
Latest Stories
NASA Plans Long-Term Moon Settlement Powered by Mini Nuclear Reactor
National | India Current AffairsDiwali Gift: Modi Government Announces 3% DA Hike for these Employees
National | India Current AffairsCurrent Affairs Quiz 01 Oct 2025: India's GDP Growth Forecast For 2025-26
Daily Current Affairs Quizzes
Comments
All Comments (0)
Join the conversation